Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34468710 | 0.90 | KDM4E (0.64) | SMN1; SMN2KMT2AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL34468780 | 0.88 | SMYD3 (0.48) | HTTSMN1; SMN2KMT2AKDM4EHSD17B10 | |
| SCHEMBL34468789 | 0.88 | KDM4E (0.55) | KMT2AKDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL16627713 | 0.88 | CNR2 (0.59) | SMN1; SMN2KMT2AKDM4EALDH1A1CNR2 | |
| SCHEMBL34468745 | 0.88 | KMT2A (0.65) | KMT2AEGLN1KDM4EHSD17B10ALDH1A1 | |
| SCHEMBL34468782 | 0.88 | KDM4E (0.58) | HTTSMN1; SMN2KMT2AKDM4EHSD17B10 | |
| SCHEMBL16627730 | 0.88 | GALR3 (0.57) | KMT2AEGLN1KDM4EHSD17B10ALDH1A1 | |
| SCHEMBL34468828 | 0.84 | MAPT (0.62) | SMN1; SMN2KMT2AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL16627888 | 0.84 | KDM4E (0.49) | KMT2AKDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL31653933 | 0.84 | ERCC1 (0.54) | KMT2AKDM4EHSD17B10ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090571-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2015050379-A1 | NOVEL QUINOLINONE DERIVATIVE AND USE THEREOF | 광주과학기술원 | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116873-A1 | APYRASE INHIBITORS | APEH, AP3M1, SRR | HTT 4290/4885SMN1; SMN2 4569/4885KMT2A 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.